Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 213Precursor Cell Lymphoblastic Leukemia-Lymphoma 174Leukemia 163Lymphoma 148Lymphoma, Non-Hodgkin 142Leukemia, Myeloid, Acute 142Myelodysplastic Syndromes 132Hodgkin Disease 123Lymphoma, Follicular 111Lymphoma, Mantle-Cell 108Multiple Myeloma 105Lymphoma, Large B-Cell, Diffuse 96Lymphoma, B-Cell, Marginal Zone 89Burkitt Lymphoma 85Myeloproliferative Disorders 73Leukemia, Myelomonocytic, Chronic 63Congenital Abnormalities 63Leukemia, Myeloid, Chronic-Phase 62Lymphoma, Large-Cell, Immunoblastic 61Leukemia, Myeloid, Accelerated Phase 60Waldenstrom Macroglobulinemia 55Leukemia, Myelogenous, Chronic, BCR-ABL Positive 53Neoplasms, Plasma Cell 52Primary Myelofibrosis 48Recurrence 46Blast Crisis 44Anemia, Refractory, with Excess of Blasts 43Lymphoma, T-Cell, Cutaneous 42Dendritic Cell Sarcoma, Interdigitating 42Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 40

Interventions

fludarabine 2Cyclophosphamide 2trametinib 1sonidegib 1ripretinib 1ribociclib 1pembrolizumab 1keyhole-limpet hemocyanin 1fludarabine phosphate 1Therapeutics 1Tetanus Toxoid 1Stem Cell Transplantation 1Sirolimus 1Psychiatric Rehabilitation 1Ocoxin 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Genistein 1Gemcitabine 1Filgrastim 1Drug Therapy 1Busulfan 1Amplified Fragment Length Polymorphism Analysis 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Germ Cell and Embryonal × fludarabine phosphate × Lymphoid × Clear all
NCT05092451 2026-05-06

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
80 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Plasma Cell, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Germ Cell and Embryonal, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡